Breakthrough Stem Cell Therapy to Be Presented at the Global Life Sciences Conference in Warsaw
(firmenpresse) - WROCLAW, POLAND -- (Marketwired) -- 07/25/13 -- Stem Cells Spin S.A., Central and Eastern Europe's leading stem cell biotechnology company with significant funding from the European Union will present at the upcoming 1st Global Life Sciences Conference in Warsaw, Poland on September 16-17th at the Warsaw Stock Exchange.
Janislaw Muszynski, President of Stem Cells Spin S.A., dr. hab. Marek Cegielski, Vice President, Research and Development Director and Lawrence Wolf, partner of Wolf & Wolf Inc., Boca Raton, FL; U.S. marketing advisor will discuss current research and future plans for a major expansion into North American markets.
Founded by scientists from Wroclaw Medical University, Stem Cells Spin S.A. is focused on the development and production of natural regenerative products derived from mammalian stem cells.
The company currently markets a line of biodermocosmetics under the brand name of Revitacell and veterinary products under the brand name of Velvetyna. Additionally, the company is pursuing major research on human medical applications.
Warsaw, the financial capital of Central and Eastern Europe is a major center of life science investment. Over 100 leading life science institutional investors, fund managers and analysts from Central and Eastern Europe will attend the conference to discuss and assess new investment opportunities.
WDM Capital, Poland's leading small cap investment bank, is the main organizer of the conference. WDM has taken over 50 companies public on the Warsaw Stock Exchange. The Warsaw Stock Exchange, the biggest securities exchange in Central and Eastern Europe, is a partner of this event.
For more information visit: .
Stem Cells Spin scientists have developed an all natural process for isolating stem cells from red deer antlers, the fastest growing of all mammalian tissues. Natural growth factors derived from these stem cells stimulate the production of human collagen and elastin and have broad medical, veterinary and biodermocosmetic application. The company has unique patented processes for isolating the stem cell cultures and naturally extracting an unlimited supply of natural growth factors. For more information see:
WDM Capital USA, LLC
(561) 705 5659
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 25.07.2013 - 14:00 Uhr
Sprache: Deutsch
News-ID 281836
Anzahl Zeichen: 0
contact information:
Town:
WROCLAW, POLAND
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 284 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Breakthrough Stem Cell Therapy to Be Presented at the Global Life Sciences Conference in Warsaw"
steht unter der journalistisch-redaktionellen Verantwortung von
WDM Capital USA LCC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
